DCV Technologies, Inc. is a private pharmaceutical company that is a manufacturer of therapeutic cancer vaccines. This company exclusively holds the licensed right to 14 antigens to help aid in ovary cancer, cervix cancer, breast cancer, colon cancer, lung cancer, and prostate cancer. This is a single location organization.